Paul B Manning acquired an additional 25.4% stake in Taysha Gene Therapies, Inc. for $14.82 million.
Paul B Manning completed the acquisition of an additional 25.4% stake in Taysha Gene Therapies, Inc. (NasdaqGS:TSHA) on August 16, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.84 USD | -0.52% | +23.32% | +118.08% |
05-14 | Taysha Gene Therapies Q1 Net Loss Narrows, Revenue Declines -- Shares Down After Hours | MT |
05-14 | Transcript : Taysha Gene Therapies, Inc., Q1 2024 Earnings Call, May 14, 2024 |
1st Jan change | Capi. | |
---|---|---|
+118.08% | 722M | |
+55.55% | 59.28B | |
+42.44% | 40.94B | |
-4.71% | 40.17B | |
-5.56% | 28.69B | |
+13.76% | 26.63B | |
-22.00% | 18.89B | |
+31.50% | 12.46B | |
+2.16% | 12.42B | |
+25.70% | 12.26B |